STONKWHISPER
← Back to Intel
Insider ActivityZBIO

Fairmount Funds Management LLC, Director at Zenas BioPharma, Inc., bought $3.0M of ZBIO

Updated Jun 10, 2026
Fairmount Funds Management LLC Director
Zenas BioPharma, Inc. · $ZBIO
$3.0M Total Value
150,000 Shares Traded
$20 Price / Share
2,359,025 Shares Owned After
2026-04-01 Filing Date

Transaction Details

InsiderFairmount Funds Management LLC
TitleDirector
CompanyZenas BioPharma, Inc.
TickerZBIO
Transaction TypePurchase
Transaction Date2026-03-31
Shares Traded150,000
Price Per Share$20
Total Value$3.0M
Filed Date2026-04-01
Accession Number0001104659-26-038546

Ownership Context

Shares Owned After Transaction2,359,025
Ownership TypeIndirect

SEC Filing

↗ View Original SEC Filing

Accession: 0001104659-26-038546

Other Insider Trades — ZBIO

Other Trades by Fairmount Funds Management LLC

Full Ticker Profile

View all insider trades, dark pool activity, congressional filings, and the Whisper Score for ZBIO — Zenas BioPharma, Inc. →

Track ZBIO insider activity in real time on The Wire →

Get alerts when Fairmount Funds Management LLC files new trades — Go Pro →

Data sourced from SEC Form 4 insider trading filings. Transaction details are as reported to the Securities and Exchange Commission. This page does not constitute financial advice. StonkWhisper presents public records — it does not verify or guarantee the accuracy of SEC filings.

Last updated: June 10, 2026 at 07:21 UTC

Want real-time data? Access The Wire for live sentiment tracking.